News & Announcements

Biotome has launched its first commercial product, the Helitope® RUO Rapid Human anti-CagA Epitope IgG ELISA Kit.

Biotome has filed an international patent application elating to Peplock, its surface-binding peptide platform for stable biomolecule immobilisation on solid surfaces.

We’re delighted to welcome Dr Maike Stentenbach to Biotome as a Postdoctoral Scientist, joining the team in January 2026.

Biotome has just completed its first feasibility study for a peptide-based lateral flow device targeting CagA-positive H. pylori—and the results exceeded expectations.